An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes

Autor: Bouma, G, Coppens, Jm, LAM TSE WK, Luini, W, Sintnicolaas, K, Levering, Wh, Sozzani, Silvano, DREXHAGE HA, VERSNEL M. A.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d6b94719ed7244c21ff4505b6e436f90
http://hdl.handle.net/11379/285

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts.

Autor: Leavis HL; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., van Daele PLA; Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands., Mulders-Manders C; Department of Internal medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Michels R; IQVIA, Amsterdam, The Netherlands., Rutgers A; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands., Legger E; Department of Pediatric Rheumatology, University Medical Center Groningen, Groningen, The Netherlands., Bijl M; Department of Rheumatology and Clinical Immunology, Martini Hospital, Groningen, The Netherlands., Hak EA; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Lam-Tse WK; Department Rheumatology, Franciscus Hospital, Rotterdam, The Netherlands., Bonte-Mineur F; Department of Rheumatology and Clinical Immunology, Maasstad Hospital, Rotterdam, The Netherlands., Fretter P; Department of Rheumatology, Treant Hospitals, Emmen/Hoogeveen/Stadskanaal, The Netherlands., Simon A; Department of Internal medicine, Radboud University Medical Center, Nijmegen, The Netherlands., van Paassen P; Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands., van der Goes MC; Department of Rheumatology, Meander Medical Center, Amersfoort, The Netherlands., Flendrie M; Department of Rheumatology, Maartenskliniek, Nijmegen, The Netherlands., Vercoutere W; Department of Rheumatology, Reumazorg Zuid-West Nederland, Goes-Terneuzen-Oostburg, The Netherlands., van Lieshout AWT; Department of Rheumatology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands., Leek A; Department of Pediatrics, University Medical Center Utrecht, Utrecht, The Netherlands., Vastert SJ; Department of Pediatrics, University Medical Center Utrecht, Utrecht, The Netherlands., Tas SW; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 03; Vol. 63 (6), pp. 1656-1663.

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial.

Autor: van Mulligen E; Rheumatology, Erasmus MC, Rotterdam, The Netherlands elise.vanmulligen@erasmusmc.nl., Weel AE; Rheumatology, Erasmus MC, Rotterdam, The Netherlands.; Rheumatology, Maasstad Hospital, Rotterdam, Zuid-Holland, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Zuid-Holland, The Netherlands., Kuijper TM; Rheumatology, Maasstad Hospital, Rotterdam, Zuid-Holland, The Netherlands., Denissen NHAM; Rheumatology, Amphia Hospital, Breda, North Brabant, The Netherlands., Gerards AH; Rheumatology, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands., de Jager MH; Rheumatology, Albert Schweitzer Hospital, Dordrecht, Zuid-Holland, The Netherlands., Lam-Tse WK; Rheumatology, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands., Hazes JM; Rheumatology, Erasmus MC, Rotterdam, The Netherlands., van der Helm-van Mil A; Rheumatology, Erasmus MC, Rotterdam, The Netherlands.; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., de Jong PHP; Rheumatology, Erasmus MC, Rotterdam, The Netherlands., Luime JJ; Rheumatology, Erasmus MC, Rotterdam, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Dec; Vol. 79 (12), pp. 1550-1556. Date of Electronic Publication: 2020 Sep 09.

Behçet's disease, hospital-based prevalence and manifestations in the Rotterdam area.

Autor: Kappen JH; Internal Medicine, section Clinical Immunology, Erasmus MC, Rotterdam, the Netherlands., van Dijk EH, Baak-Dijkstra M, van Daele PL, Lam-Tse WK, van Hagen PM, van Laar JA

Publikováno v: The Netherlands journal of medicine [Neth J Med] 2015 Dec; Vol. 73 (10), pp. 471-7.